Dudediligence.

Orchestra BioMed Holdings, Inc

OBIONASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$987,000Sep ’24$253,000Dec ’24$868,000Mar ’25$836,000Jun ’25$861,000Sep ’25$30.9MDec ’25$110,000Mar ’26$88,000Jun ’26
Net income, by quarter
−$15.4MSep ’24−$16.2MDec ’24−$18.8MMar ’25−$19.4MJun ’25−$20.8MSep ’25$6.2MDec ’25−$20.7MMar ’26−$23.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$3.5M$2.8M$2.6M$33.5M
Gross profitnone on file$3.3M$2.6M$2.4M$33.3M
Operating income−$394,756−$32.7M−$51.5M−$64.3M−$51.8M
Net income−$378,753−$33.6M−$49.1M−$61.0M−$52.7M
Operating cash flow−$272,362−$29.3M−$46.1M−$50.6M−$49.0M
Free cash flownone on file−$29.9M−$46.2M−$50.8M−$49.5M
Cash$1.8M$19.8M$30.6M$22.3M$34.7M
Debtnone on filenone on filenone on file$15.0M$15.0M
Shares outstanding4.5M20.2M35.8M38.2M57.0M